Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Systemic Lupus Erythematosus”

289 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 289 results

Post-approval studies (Phase 4)Study completedNCT03098823
What this trial is testing

A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE

Who this might be right for
Lupus Erythematosus, SystemicLupus ErythematosusFatigue
Ampel BioSolutions, LLC 62
Not applicableEnded earlyNCT05379725
What this trial is testing

Mediterranean vs. High-Fermented-Food Diet Adherence on Inflammation in Lupus

Who this might be right for
Lupus Erythematosus, Systemic
University of Florida 5
Large-scale testing (Phase 3)Study completedNCT02446899
What this trial is testing

Efficacy and Safety of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

Who this might be right for
Active Systemic Lupus Erythematosus
AstraZeneca 373
Not applicableStudy completedNCT01858792
What this trial is testing

A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies

Who this might be right for
Lupus Erythematosus, Discoid
Human Genome Sciences Inc., a GSK Company 1
Testing effectiveness (Phase 2)Study completedNCT03393013
What this trial is testing

KZR-616 in Patients With SLE With and Without Lupus Nephritis

Who this might be right for
Lupus NephritisSystemic Lupus Erythematosus
Kezar Life Sciences, Inc. 69
Large-scale testing (Phase 3)Study completedNCT04931563
What this trial is testing

Anifrolumab Asian PhIII Efficacy Study for Systemic Lupus Erythematosus (SLE)

Who this might be right for
Active Systemic Lupus Erythematosus
AstraZeneca 277
Not applicableLooking for participantsNCT06880653
What this trial is testing

Dose Response of Exercise for Arthritis Management

Who this might be right for
ArthritisRheumatoid Arthritis (RA)Gout+3 more
University of South Carolina 285
Not applicableStudy completedNCT07193745
What this trial is testing

Respiratory Function, Physical Activity and Fatigue in SLE

Who this might be right for
Systemic Lupus Erythematosus
Melis Usul 50
Large-scale testing (Phase 3)Study completedNCT02446912
What this trial is testing

Efficacy and Safety of Two Doses of Anifrolumab Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

Who this might be right for
Active Systemic Lupus Erythematosus
AstraZeneca 460
Not applicableStudy completedNCT03107442
What this trial is testing

Exercise and Arterial Stiffness in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Fundación Pública Andaluza para la Investigación Biomédica Andalucía Oriental 58
Large-scale testing (Phase 3)UnknownNCT05432531
What this trial is testing

Efficiency of Use of Baracetinib in Treatment of Lupus Nephritis

Who this might be right for
Lupus Nephritis
Assiut University 60
Very early researchUnknownNCT04726553
What this trial is testing

Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Oklahoma Medical Research Foundation 20
Not applicableStudy completedNCT07071233
What this trial is testing

Efficacy of Vitamin C Supplementation on Serum TNF-α Levels and Disease Activity in SLE Patients

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Universitas Sriwijaya 38
Not applicableNot Yet RecruitingNCT07483541
What this trial is testing

Identification of Modifiable Sleep-related Factors in Patients With Systemic Lupus Erythematosus.

Who this might be right for
Lupus Erythematosus
Investigación en Hemofilia y Fisioterapia 250
Testing effectiveness (Phase 2)Study completedNCT02472795
What this trial is testing

Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Viatris Innovation GmbH 105
Large-scale testing (Phase 3)Active Not RecruitingNCT05617677
What this trial is testing

Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Bristol-Myers Squibb 516
Testing effectiveness (Phase 2)Study completedNCT05430087
What this trial is testing

Vitamin D and Curcumin Piperine Attenuates Disease Activity and Cytokine Levels in Systemic Lupus Erythematosus Patients

Who this might be right for
Systemic Lupus Erythematosus
Saiful Anwar Hospital 45
Testing effectiveness (Phase 2)Looking for participantsNCT07038382
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability of Human Sialidase Fusion Protein (HLX79) in Combination With Rituximab Injection Versus Placebo in Patients With Active Glomerulonephritis

Who this might be right for
Membranous NephropathyLupus Nephritis (LN)
Shanghai Henlius Biotech 24
Not applicableLooking for participantsNCT07666711
What this trial is testing

Biomarker Development for Autoimmune Disorders Involving the Kidneys

Who this might be right for
Lupus NephritisSystemic Lupus Erythematosus
Oslo University Hospital 500
Testing effectiveness (Phase 2)Study completedNCT01838694
What this trial is testing

Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.

Who this might be right for
Lupus Erythematosus, Systemic
Invion, Inc. 30
Next Page